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 In almost 2 decades since the onset of the 21st century, there has been an explosion in 
interest in hyponatremia, which has resulted in a marked increase in the number of 
publications on the topic. This is remarkable as there is no evidence that the incidence 
or prevalence of the condition is increasing. Unlike new diseases, such as antibiotic-
resistant infections or complications of the effects of cancer therapy, hyponatremia 
has always been there. However, the increased interest in hyponatremia reflects an 
improved understanding of the effects of hyponatremia on both morbidity and mor-
tality, and equally, a recognition of the large gaps in our knowledge of this area. The 
expansion in the potential ramifications of hyponatremia, on falls, fractures and os-
teoporosis, as well as its association with increased mortality has focused on how 
much more still needs to be done to prove the causal relationships and to ascertain 
the value of therapeutic intervention. This has resulted in an academic environment 
characterised by healthy debate – and occasional dispute – among groups involved in 
hyponatremia research, which is beneficial since it further invigorates interest in hy-
ponatremia. As a result, there has been a steady rise in publications on the topic of 
hyponatremia since the 1940s ( Fig. 1 ). 
 However, the current clinical and academic interests in hyponatremia are relative-
ly recent. For many years, hyponatremia was a topic that did not generate enthusiasm 
among journal editors or granting agencies, and indeed, was not attached to a spe-
cific sub-discipline of medicine. A small number of endocrinologists and nephrolo-
gists nurtured research programs that contributed to gathering knowledge on hypo-
natremia, but the majority of hospitals had no specialists who developed services for 
hyponatremic patients, or who set standards for investigations and management of 
the condition. The evolution of our knowledge on the physiology of the control of 
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2  Thompson · Peri · Verbalis 
serum [Na + ] concentration, and how that knowledge transformed the clinical ap-
proach to diagnosis and management of hyponatremia, is a journey worthy of some 
comment.
 Early Publications and Theories 
 Although there have been a number of papers that referred to hyponatremia in the 
context of water intoxication, the first systematic review of conditions marked by 
abnormalities of water and salt balance in PubMed was published in 1947 in the Brit-
ish Medical Journal  [1] . Marriott’s treatise focused on the prevailing interpretation 
of the time, that perturbations in serum [Na + ] concentration could be explained on 
the basis of altered dynamics of sodium balance; in other words, that abnormal so-
dium intake or excretion was responsible for changes in serum [Na + ] concentration, 
including hyponatremia. This view, which predominated the field for many years, is 
in direct contrast to modern interpretations of the pathophysiology of hyponatre-
mia, which dictate that abnormalities of water handling, as mediated by the antidi-
uretic actions of arginine vasopressin (AVP) are responsible for a large number, if 
not most cases of hyponatremia  [2] . The lack of awareness of the important role of 
water retention in hyponatremia was reflected in the first case series of patients who 
had hyponatremia complicating pulmonary tuberculosis  [3] . Published as an ab-
stract of a presentation to the American Society for Clinical Investigation, this paper 
detailed the clinical characteristics of 10 patients with advanced pulmonary tubercu-
losis, complicated by malnutrition, in whom hyponatremia (plasma sodium 123–130 
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 Fig. 1. Cumulative numbers of PubMed publications on hyponatremia, by decade. 
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vations indicated that there was no “frank evidence” of renal or adrenal disease, 
though two patients did test positive for adrenal insufficiency, using the archaic 
Levy-Power-Kepler test. The authors documented renal retention of sodium in 4 pa-
tients who were administered desoxycorticosterone, which raises the possibility that 
some of the patients were aldosterone deficient, perhaps due to tuberculous adrenal-
itis; 2 patients had recovery of serum [Na + ] with improvement of their clinical con-
dition, which suggests the possibility of the syndrome of inappropriate antidiuresis 
(SIAD) rather than adrenal failure. The authors concluded that the underlying 
pathophysiology was due to the “primary reduction in intracellular osmolality,” and 
hypothesized that the increased renal sodium excretion reflected a homeostatic at-
tempt to reduce extracellular tonicity to equilibrate with the reduced intracellular 
osmolarity. It is likely, without the full diagnostic criteria that we would consider es-
sential today, that the case series was heterogeneous, with some patients having tu-
berculous adrenal destruction, and perhaps more having straightforward SIAD. 
However, despite the fastidious clinical documentation of the series, there was no 
stated awareness of the possibility of altered water excretion, either due to cortisol 
deficiency or excess AVP secretion, which are far likelier candidate pathophysiolo-
gies based on our current understanding of hyponatremia. 
 In subsequent years, the association of hyponatremia with hepatic cirrhosis  [4] and 
congestive cardiac failure  [5] were formally documented, but a key step forward came 
with the first description of what we now understand as the commonest cause of hy-
ponatremia, SIAD.
 Early Descriptions of SIAD 
 A critical advancement in our understanding of the pathogenesis of hyponatremia 
came in 1957 as a result of a series of clinical observations of 2 patients with the diag-
nosis of hyponatremia in the setting of bronchogenic carcinoma  [6] . During the 
course of hospital admission, serum [Na+] fell significantly in both patients, to nadirs 
of 103 and 105 mEq/L, respectively. In the first case, it was found that ad libitum salt 
intake and slightly restricted fluid intake improved hyponatremia, maintaining near 
normal plasma sodium concentration. In the second case, however, hyponatremia 
persisted, despite the use of large amounts of salt, and was accompanied by a contin-
uous loss of sodium in the urine. There were no signs of extracellular fluid sodium or 
fluid depletion, and both patients revealed normal kidney, thyroid and adrenal func-
tions. The urine remained continuously hypertonic compared to the plasma as serum 
[Na+] fell. Transient elevations of serum [Na + ] were found with large loads of hyper-
tonic saline infusion followed by a significant diuresis of dilute urine. Fluid restriction 
in both subjects resulted in sodium retention and a return of serum [Na+] to near 
normal values. Conversely, restoration of free fluid intake worsened the “sodium-
losing syndrome.”  
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4  Thompson · Peri · Verbalis 
 The authors advanced the hypothesis that inappropriate urine concentration oc-
curred in response to an antidiuretic hormone circulating in the plasma. Although 
they had no specific assay to measure plasma AVP concentrations, Schwartz et al. [6] 
were able to define the main principles of the diagnosis and treatment of this condi-
tion, such that their seminal paper remains the gold standard description of SIAD 
today. Interestingly, the fluid restriction that they used as a treatment for hyponatre-
mia continued to be endorsed for years  [7] , and is still recommended by recent inter-
national guidelines as the first-line treatment for mildly symptomatic SIAD  [8] .
 Measurement of Plasma Vasopressin Levels 
 The ability to measure plasma concentrations of AVP was a major advancement, as 
this allowed definition of the characteristics of the regulation of secretion of the an-
tidiuretic hormone for the first time [10, 11]. Prior to the development of sensitive 
radioimmunoassays for the measurement of AVP in plasma, our knowledge of the 
physiology of AVP release and action was implied from the use of urine osmolality as 
a bioassay for the action of AVP. In the 1970s, a number of specific antibodies to AVP 
were developed from animal models, and used to develop sensitive radioimmunoas-
says, which were used in clinical studies to measure AVP in plasma and urine  [9] . Us-
ing these new assays, researchers defined the physiology of AVP secretion in response 
to osmotic and non-osmotic stimuli  [12] . With particular relevance to hyponatremia, 
Robertson et al.  [13] were able to demonstrate that plasma AVP concentrations were 
elevated in >90% of cases of SIAD  [13] , thus proving the clinical hypothesis made by 
Schwartz et al.  [6] 25 years earlier. 
 Development of Animal Models of Hyponatremia 
 Although the availability of radioimmunoassays allowed the characterization of the 
physiological control of AVP secretion and the relationship of abnormal osmoregula-
tion to the development of hyponatremia, the establishment of animal models of hy-
ponatremia allowed more complex pathophysiological issues to be explored. The neu-
rological sequelae and high mortality of acute and chronic hyponatremia did not 
readily allow clinical research protocols in humans, which suggested the need for 
translational studies in animal models. 
 The first published description of symptoms of water intoxication in humans was 
reported in 1923  [14] , followed by studies in experimental animals that showed cere-
bral edema as the likely cause of neurological symptoms  [15] . Not much later, the first 
case of fatal cerebral edema was reported in a post-operative patient  [16] , which was 
quickly followed just 3 years later by a report of the first successful treatment of hy-
ponatremic encephalopathy using hypertonic NaCl  [17] , a remarkable example of 
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 Historical Aspects of Hyponatremia 5
rapid translation from basic studies in animals to an effective clinical therapy that is 
still used today.
 Over subsequent years, many studies were carried out in animals using protocols 
employing administration of AVP in conjunction with water loading, usually by in-
traperitoneal administration of 5% dextrose solution. Although important discoveries 
were made, notably the first description of brain electrolyte losses during adaptation 
to hyponatremia  [18] , all of these early models were accompanied by high rates of 
morbidity and mortality, making studies of chronic hyponatremia difficult to perform 
and even more challenging to interpret. A more stable rat model of SIAD was devel-
oped in the US using desmopressin-induced antidiuresis in combination with water 
loading via self-ingestion of a liquid diet that had negligible effects on mortality and 
proved to be a good model for human osmoregulation  [19] , which then allowed stud-
ies of the abnormal osmoregulation during sustained hyponatremia  [20] . Having es-
tablished credentials as a valid animal model for human SIAD, a series of studies was 
then able to establish the patterns of osmolyte fluxes across the brain and the abnor-
malities that were present during hyponatremia  [21] ; the data from these studies were 
also used to develop a model to explore the abnormal osmolyte fluxes after overly 
rapid correction of hyponatremia  [22] . The knowledge gained from the use of an ex-
perimental animal model of SIAD has provided the basis for much of what we under-
stand about the pathophysiology of osmotic demyelination, the dreaded sequel of 
overly rapid correction of chronic hyponatremia  [23] , which can lead to spastic para-
plegia and cranial nerve palsies. The knowledge gained from these translational stud-
ies complemented observational studies in human patients [27], which in combina-
tion directly led to the guidelines for the treatment of hyponatremia that reduced the 
risk of osmotic demyelination  [8] .
 Recent Advances 
 The identification of the aquaporin water channels, particularly the AVP-regulated 
collecting duct aquaporin-2 channel, has significantly elevated our understanding of 
the actions of AVP in the reabsorption of water from the renal tubules  [24] . This 
fundamental discovery was a prime example of the ability of translational basic sci-
ence studies to enable clinicians to better understand body physiology and patho-
physiology at a clinically relevant level. Many of the inherited mutations and ac-
quired metabolic malfunctions of the aquaporins produce polyuria rather than hy-
ponatremia. However, the unusual mutation responsible for the nephrogenic 
syndrome of antidiuresis  [25] has been shown to cause hyponatremia despite unde-
tectable plasma concentrations of AVP, because of a gain-of-function mutation of 
the AVP V2 receptor, leading to the recruitment of aquaporin-2 in large numbers to 
the apical membrane of collecting duct principal cells resulting in AVP-independent 
constitutive antidiuresis. 
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6  Thompson · Peri · Verbalis 
 The discovery of the AVP receptor antagonists (vaptans) has also been a major ad-
vancement in the therapeutic approach to hyponatremia, with an emphasis on SIAD. 
The indications and therapeutic advantages of this class of drugs will be covered in 
depth in the relevant chapters on SIAD, but it is clear from existing randomized clin-
ical trials that they are effective for the treatment of hyponatremia, and clinical expe-
rience has shown few serious adverse reactions. A recent review surmised that reti-
cence about more widespread use are based partly on the economics of therapy and 
partly on a lack of hard end-point data  [26] . The need for better prospective data to 
inform our diagnostic and therapeutic decisions in hyponatremic patients will be a 
recurrent theme in this book.
 It gives us great pleasure as editors to introduce this volume of work on the subject 
of hyponatremia. For each of us, our study and practice of endocrinology has been 
dominated by an interest in this fascinating subject. It has been a pleasure to witness 
the upsurge in interest and publications on hyponatremia over the last 2 decades, as 
clearly illustrated in  Figure 1 . The chapters in this book have been selected by editors 
to update key areas of recent research in hyponatremia that have fuelled the recent 
rise in publications. To do this, we have gathered a team of truly expert enthusiasts to 
cover these important topics. We hope that the volume will be a useful and important 
summary of our evolving understanding of hyponatremia, and will stimulate further 
research into the still large number of questions that remain to be answered about this 
important disorder.
 Even a cursory glance at  Figure 1 is sufficient to comprehend the steady increase 
in research on hyponatremia, with well over 4,000 publications up to the end of 2017. 
The editors fully expect that this trend will not only continue, but will accelerate with 
the increasing volume of basic, translational and clinical studies in sodium and water 
metabolism.
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